CLINICAL_TRIALS
trial_result
· 2021-09-30
Clinical Trial Update: Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites [Phase 2]
Summary
Phase 2 clinical trial assessing safety and activity of local MBN-101 for infected bone sites has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Microbion Corporation | Conditions: Bacterial Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-09-30